Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
165
NCT01711398
Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2012
Completion: Feb 28, 2015
NCT05474313
A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW
Phase: N/A
Role: Collaborator
Start: Apr 8, 2022
Completion: Dec 31, 2023